Sunshine Biopharma (SBFM) Invested Capital (2018 - 2019)

Sunshine Biopharma's (SBFM) quarterly Invested Capital came in at $27541.0 in Q3 2019, down 1.18% on a QoQ basis from $27869.0 in Q2 2019.

Sunshine Biopharma (SBFM) Invested Capital (2018 - 2019) Analysis & Trends

Sunshine Biopharma (SBFM) has 2 years of Invested Capital data on file, last reported at $27541.0 in Q3 2019.

Quarterly Invested Capital changed N/A year-over-year to $27541.0 in Q3 2019, while the trailing twelve-month figure through Jun 2020 was $27541.0 (down 74.57% YoY) and the FY2018 annual result came in at $20871.0, changed N/A from the prior year.
Invested Capital slipped to $27541.0 in Q3 2019, from $27869.0 in the prior quarter.
In the past five years, Invested Capital ranged from a high of $59558.0 in Q1 2019 to a low of $20871.0 in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-	9.90 Bn
2	Teva Pharmaceutical Industries	43.28 Bn	39.62 Bn	2.15 Bn	4.50 Bn
3	Zoetis	31.78 Bn	30.11 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.71 Bn	22.91 Bn	5.10 Bn	3.74 Bn
5	United Therapeutics	22.25 Bn	19.59 Bn	683.80 Mn	-
6	Viatris	18.72 Bn	17.83 Bn	1.46 Bn	1.74 Bn
7	Neurocrine Biosciences	15.57 Bn	15.18 Bn	935.80 Mn	-
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn	73.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.97 Bn	-	630.00 Mn
10	Sunshine Biopharma	1.53 Mn	-12.22 Mn	2.43 Mn	-

Download Data